As of 2024-12-14, the Intrinsic Value of WAVE Life Sciences Ltd (WVE) is
0.67 USD. This WVE valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y).
With the current market price of 13.85 USD, the upside of WAVE Life Sciences Ltd is
-95.20%.
The range of the Intrinsic Value is 0.74 - 0.38 USD
WVE Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(79.70) - (5.75) |
(11.83) |
-185.4% |
| DCF (Growth 10y) |
(8.96) - (108.05) |
(17.14) |
-223.7% |
| DCF (EBITDA 5y) |
0.74 - 0.38 |
0.67 |
-95.2% |
| DCF (EBITDA 10y) |
(0.94) - (1.59) |
(1,234.50) |
-123450.0% |
| Fair Value |
-7.68 - -7.68 |
-7.68 |
-155.43% |
| P/E |
(3.55) - (9.16) |
(8.18) |
-159.0% |
| EV/EBITDA |
1.21 - (0.25) |
0.98 |
-92.9% |
| EPV |
(8.75) - (11.87) |
(10.31) |
-174.4% |
| DDM - Stable |
(11.25) - (117.84) |
(64.55) |
-566.0% |
| DDM - Multi |
(3.26) - (26.93) |
(5.85) |
-142.2% |
WVE Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2,112.40 |
| Beta |
2.41 |
| Outstanding shares (mil) |
152.52 |
| Enterprise Value (mil) |
1,801.45 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.26% |
| Cost of Debt |
5.00% |
| WACC |
6.12% |